PrimeRFP - AI-Powered RFP Solutions
PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DP23F58358510110923!zanamivir for INHAL — Glaxosmithkline LLC

Glaxosmithkline LLC holds $3.0B across 194 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent SPE2DP22D0009. PoP ended Mar 18, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Dla Troop Support
Awarding office
Glaxosmithkline LLC
Recipient
Mar 18, 2024
PoP end
$158K
Obligated
$158K
Potential
325412
NAICS
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Glaxosmithkline LLC — $90

Contract facts

Federal
Contract numberSPE2DP23F5835
Also listed asSPE2DP-23-F-5835
Also listed asSPE2DP22D0009-SPE2DP23F5835
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentGlaxosmithkline LLC
CAGE667E9
UEIFRHTPHMZMX47
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505
Parent IDIQ / IDVSPE2DP22D0009
Place of performanceDURHAM NC
Pricing typeFirm Fixed Price
Extent competedNot Competed
PoP startAug 29, 2023
PoP end (current)Mar 18, 2024
Obligated$158K
Current value$158K
Potential value$158K

8510110923!ZANAMIVIR FOR INHAL is a federal award for Dla Troop Support held by Glaxosmithkline LLC. Estimated value $158K ($158K obligated). Current period of performance ends Mar 18, 2024. Place of performance: DURHAM NC.

Recompete timing

Public
● Past PoP end (886 days ago)

Current PoP ended Mar 18, 2024 (886 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Glaxosmithkline LLC — $3.0B obligated across 194 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($3.0B) · all agencies
Department of Health and Human Services (HHS)$3.0B · 100%Department of Defense (DOD)$1.7M · 0%Department of Veterans Affairs (VA)$1.5M · 0%Department of State (DOS)$1.2M · 0%
Open full company profile →

Related awards

Same parent · incumbent
75A50125F61019
FILL/FINISH DOD AS03 ADJUVANT CLIN 1006E
$491K
Aug 30, 2026
75A50126F61020
TWO-WAY IMMUNOGENICITY TESTING ON EXISTING CLINICAL TRIAL SERA TO IMMUNOGENICITY SUPERIOR…
$493K
Oct 29, 2026
15F06724F0001366
GSK TRAVEL VACCINES
$115K
Dec 31, 2026
15F06726F0000234
GSK VACCINES TERMS AND CONDITIONS REMAIN THE SAME - BPA 15F06722A0000187
$105K
Dec 31, 2026
75A50124F61014
THIS TASK ORDER ESTABLISHES SERVICES FOR H5 PANDEMIC READINESS FOR ACQUISITION OF MEDICAL …
$18.4M
Feb 21, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DP23F5835?

SPE2DP23F5835 (8510110923!zanamivir for INHAL) is a Dla Troop Support award with a potential value of $158K, currently held by Glaxosmithkline LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is SPE2DP-23-F-5835?

SPE2DP-23-F-5835 is the dashed form of PIID SPE2DP23F5835 (8510110923!zanamivir for INHAL), held by Glaxosmithkline LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded SPE2DP23F5835?

Dla Troop Support awarded SPE2DP23F5835 to Glaxosmithkline LLC (potential $158K).

Who is the incumbent on SPE2DP23F5835?

Glaxosmithkline LLC is the incumbent with $3.0B across 194 related awards in SCOUT’s public footprint. The current period of performance ends Mar 18, 2024.

When does Glaxosmithkline LLC’s SPE2DP23F5835 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 18, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DP23F5835